Spots Global Cancer Trial Database for Recommendations for the Treatment of Children With Burkitt's Lymphoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Recommendations for the Treatment of Children With Burkitt's Lymphoma

Official Title: Recommendations for the Treatment of Children With Burkitt's Lymphoma

Study ID: NCT04425421

Conditions

Burkitt Lymphoma

Interventions

OBSERVATIONAL

Study Description

Brief Summary: This is the 4th LMB study by the French African Pediatric Oncology Group (GFAOP). The study hopes to be able to evaluate children earlier with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for the stage IV disease.

Detailed Description: This is the 4th Burkitt's Lymphoma (LMB) study by the GFAOP group. This study hopes to include at least 14 Sub Saharian countries some of whom have never participated in a LMB study. The evaluation of improvement in early diagnosis should be possible in this study. The study hopes to be able to evaluate children earlier, with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for children with a stage IV disease.